Results 171 to 180 of about 75,125 (295)

OCT4-induced oligodendrocyte progenitor cells promote remyelination and ameliorate disease [PDF]

open access: gold, 2022
Wonjin Yun   +17 more
openalex   +1 more source

Tumor‐Resident Mast Cells Facilitated Breast Cancer Progression via Activating Type I Interferon Pathway

open access: yesMedComm – Oncology, Volume 5, Issue 2, June 2026.
Breast cancer cell‐derived stem cell factor (SCF) activates c‐KIT‐mediated MAPK/ERK signaling in mast cells, inducing IFNB1 production. Mast cell‐derived IFNB1 then engages the IFNAR1‐STAT1 axis in breast cancer cells, activating the Type I interferon pathway to promote tumor stemness and progression.
Siqin Li   +16 more
wiley   +1 more source

Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells [PDF]

open access: gold, 2014
Sei‐Myoung Han   +7 more
openalex   +1 more source

Zinc‐Coordination‐Driven Pyroptosis Nano‐Inductor Sensitizes Colorectal Cancer Chemo‐Immunotherapy by Specific Delivery and Cell Stemness Suppression

open access: yesMedComm – Oncology, Volume 5, Issue 2, June 2026.
CD44‐targeted CNPs co‐deliver Zn2+ and MIT–ALA to CRC cells. Intracellularly, Zn2+ inhibits GLUT1‐dependent glycolysis, and ALA disrupts mitochondrial function, driving metabolic exhaustion in CSCs. This mitochondrial damage primes GSDMD‐mediated pyroptosis, accompanied by the release of pro‐inflammatory cytokines (IL‑1β, IL‑18).
Qinxia Chang   +8 more
wiley   +1 more source

Skin Boosters: 2026 Updated

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Skin boosters are increasingly used to improve dermal quality through injectable and device‐assisted approaches; however, definitions and clinical evidence remain heterogeneous. Aims To provide an updated overview and propose a practical classification of skin boosters, including mechanisms, delivery methods, clinical outcomes, and limitations.
Kyu‐ho Yi   +7 more
wiley   +1 more source

Oct4, a novel marker for human gastric cancer [PDF]

open access: bronze, 2009
Zhong Chen   +10 more
openalex   +1 more source

Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors [PDF]

open access: gold, 2014
Jiabiao Hu   +14 more
openalex   +1 more source

Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells

open access: gold, 2023
Fabien Almairac   +14 more
openalex   +1 more source

Perivascular cell-specific knockout of the stem cell pluripotency gene Oct4 inhibits angiogenesis [PDF]

open access: gold, 2019
Daniel L. Hess   +8 more
openalex   +1 more source

PRX5 as a critical driver of colorectal cancer stemness and tumorigenicity. [PDF]

open access: yesRedox Rep
Lee SW   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy